39.17
price down icon4.14%   -1.69
pre-market  Pre-mercato:  38.40   -0.77   -1.97%
loading

Mineralys Therapeutics Inc Borsa (MLYS) Ultime notizie

pulisher
02:31 AM

Why Mineralys Therapeutics Inc. stock is favored by top institutionsPortfolio Growth Summary & Consistent Return Investment Signals - newser.com

02:31 AM
pulisher
Nov 03, 2025

Will Mineralys Therapeutics Inc. stock remain a Wall Street favoriteTrade Ideas & Verified Entry Point Detection - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Mineralys Therapeutics Inc. stock recover faster than marketFed Meeting & Growth Focused Stock Pick Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Momentum divergence signals in Mineralys Therapeutics Inc. chartEarnings Risk Report & Expert Approved Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What moving averages say about Mineralys Therapeutics Inc.Quarterly Market Review & Verified Entry Point Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Mineralys Therapeutics (NASDAQ: MLYS) sets Q3 results call for 4:30 p.m. ET - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Price action breakdown for Mineralys Therapeutics Inc.Weekly Volume Report & Weekly Breakout Opportunity Watchlist - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Multi factor analysis applied to Mineralys Therapeutics Inc.July 2025 Summary & Real-Time Market Sentiment Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How rising interest rates impact Mineralys Therapeutics Inc. stockQuarterly Growth Report & Low Drawdown Trading Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Mineralys Therapeutics Inc. hit a new high this monthForecast Cut & Low Drawdown Momentum Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Mineralys Therapeutics Inc. stock reacts to Fed rate cutsWeekly Profit Recap & Verified Momentum Watchlists - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Real time scanner hits for Mineralys Therapeutics Inc. explainedPortfolio Risk Report & Smart Swing Trading Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Heatmap analysis for Mineralys Therapeutics Inc. and competitorsWeekly Market Outlook & Weekly Market Pulse Updates - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Will Mineralys Therapeutics Inc. stock maintain growth storyTrade Analysis Summary & Capital Efficiency Focused Strategies - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Mineralys Therapeutics Inc. stock trendline breakdownJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Jennison Associates LLC Sells 743,711 Shares of Mineralys Therapeutics, Inc. $MLYS - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

Is Mineralys Therapeutics Inc. stock a dividend growth opportunity2025 Technical Patterns & High Accuracy Swing Entry Alerts - newser.com

Nov 02, 2025
pulisher
Oct 31, 2025

Has Mineralys Therapeutics Inc. found a price floorQuarterly Earnings Summary & Short-Term High Return Strategies - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Mineralys Therapeutics (NASDAQ:MLYS) Price Target Raised to $52.00 - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Analysts Conflicted on These Healthcare Names: Bausch Health Companies (BHC), Thermo Fisher (TMO) and Mineralys Therapeutics, Inc. (MLYS) - The Globe and Mail

Oct 31, 2025
pulisher
Oct 31, 2025

Mineralys Therapeutics to Present Key Lorundrostat Data at ASN Kidney Week 2025 - MSN

Oct 31, 2025
pulisher
Oct 31, 2025

Is Mineralys Therapeutics Inc a good long term investmentMarket Breadth Indicators & Free High Velocity Capital Growth - earlytimes.in

Oct 31, 2025
pulisher
Oct 31, 2025

Ranking Mineralys Therapeutics Inc. among high performing stocks via toolsMarket Trend Review & Verified Technical Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can machine learning forecast Mineralys Therapeutics Inc. recoveryQuarterly Trade Review & Capital Efficient Trade Techniques - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Mineralys Therapeutics prices upsized $250M stock offering - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

Why Mineralys Therapeutics Stock is Climbing Higher - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

Mineralys Therapeutics price target raised to $52 from $42 at H.C. Wainwright - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

HC Wainwright & Co. Maintains Mineralys Therapeutics (MLYS) Buy Recommendation - Nasdaq

Oct 30, 2025
pulisher
Oct 29, 2025

Is Mineralys Therapeutics Inc. stock recession proofJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - newser.com

Oct 29, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Capitalizzazione:     |  Volume (24 ore):